Bhagyashri Bhole

Pain Relief Medication Market 2020: Key companies Profile, their market Share and Growth Insights to 2025

2020-02-18T12:07:03.765Z

Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain.

The growth of the Global Pain Relief Medication Market is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market.

According to MRFR analysis, Pain Relief Medication Market Size is expected to register a CAGR of 4.73% during the forecast period of 2019 to 2025 and held a value of USD 55,275 million in 2018.

Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) for the management of moderate to severe pain associated with endometriosis.

Pain Relief Medication Market Key Players

Some of the key players in the global pain relief medication market are AbbVie Inc. (US), Allergan plc (Ireland), Astellas Pharma Inc. (Japan), Bayer (Germany), Biogen Idec (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb (US), Eli Lilly and Company (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Pfizer, Inc. (US), Purdue Pharma (US), Sanofi (France), and Teva Pharmaceutical Industries Ltd (Israel).

Pain Relief Medication Market Segmentation

The global pain relief medication market has been segmented based on drug class, indication, and distribution channel.

The market, based on drug class, has been divided into nonsteroidal anti-inflammatory drugs, opioids, COX-2 inhibitors, and others. The nonsteroidal anti-inflammatory drug segment is likely to be the largest during the review period due to the high efficacy rate of this drug class. The opioids segment is predicted to be the fastest-growing due to the increasing awareness about the drugs in this class in the pain relief medication market.

The global pain relief medication market has been segmented based on the indication, into cancer pain, neuropathic pain, musculoskeletal pain, inflammatory conditions, and others. The cancer pain segment is expected to hold the majority share of the market owing to the increasing people suffering from this type of pain. The neuropathic pain segment is expected to be the fastest-growing due to the rising patient population in different economies.

The global pain relief medication market, by distribution channel, has been divided into hospital and retail pharmacies, and online pharmacies. The hospitals and retail pharmacies segment is projected to hold the largest share of the market due to the increasing number of hospital in-visits. The online pharmacies segment is expected to be the fastest growing owing to the rise in the awareness about online distribution network.

Browse More Information @ https://www.marketresearchfuture.com/reports/pain-relief-medication-market-8431

Pain Relief Medication Market Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the rise in chronic diseases in this region. In Brazil, chronic pain is a widespread clinical condition, affecting between 28% and 41% of the Brazilian population. The pain relief medication market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European pain relief medication market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pain relief medication market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rise in initiatives by public and private organizations, the market in Asia-Pacific is expected to be the fastest-growing. The pain relief medication market in the Middle East & Africa has been divided into the Middle East and Africa.

Light Therapy Market 2020 Global Trend, Segmentation and Opportunities, Forecast 2025

2020-02-18T10:47:46.403Z

Market Research Future (MRFR) considers the rising number of dermatological disorders as the major reason behind the market growth of the light therapy market. Among other major reasons, growing demand for non-invasive methods, treatment for psychological disorders, and better funding for research and development projects are deemed to play crucial roles in taking the market forward.

The Global Light Therapy Market Size has an opportunity to scale a growth valuation of USD 1,112.16 Million by 2025 with a moderate CAGR of 5.1% in the forecast period that covers 2019 to 2025.

However, side-effects like eye pain, nausea, headache, itching, burning sensation, and agitation can deter the market from having a smooth run. Its lack of awareness in several countries can also hold back the growth.

Competitive Landscape:

The market for light therapy is witnessing a surge in strategic moves that ensure market growth. This would depend much on the performance of the market players like BioPhotas (US), Beurer (Germany), Northern Light Technology (Canada), Koninklijke Philips (Netherlands), Verilux (US), Nature Bright (Taiwan), Chal-Tec GmbH (Germany), Lumie (UK), Lucimed SA (Belgium), Zepter International (Switzerland), and others. These companies have their recent moves profiled by MRFR to understand the market movements in a proper way.

Recently, the FDA approved Revian Red dual-wavelength LED light therapy (PhotonMD) for the treatment of hair loss, which can boost the market considerably.

Segmentation

The global market for light therapy has been segmented in the report on the basis of product, application, light type, and end user.

By product, the market for light therapy can be segmented into lightbox, floor & desk lamp, light visor, dawn simulator, handheld devices for skin treatment (HDST), light therapy bulbs, and others. The ‘others’ segment would include Bluewave technology and light on a timer. The HDST segment has the largest market share as patients prefer this for its ability to cope up with the home care setting. The light visor setting is the fastest-growing segment and its portability is playing in favor of the market.

By application, the global market report on the light therapy can be segmented into psoriasis, vitiligo, eczema, acne vulgaris, sleeping disorders, seasonal affective disorder (SAD), and others that include bone injuries and joint pain. The sleeping disorder segment has the widest market coverage and psoriasis has the opportunity to register the fastest growth rate for the foreseeable future.

By light type, the market report focusing on the study of light therapy segments the market into blue light, white light, red light, and others. The blue light segment covers the widest portion of the market as its takers are growing to treat sun damage and skin cancer. The red light has the fastest growth rate and its application to treat joint pain and arthritis is growing. The ‘others’ include purple light and yellow light.

By end user, the report segments the market into homecare settings, dermatology clinics, and others. The home care setting covers the maximum ground as it is cost affordable. The ‘others’ segment includes workplace and salons.

Browse More Information @ https://www.marketresearchfuture.com/reports/light-therapy-market-8366

Regional Analysis:

The Americas is showing great progress owing to the huge demand it is getting from the rising demand for non-invasive procedures. In addition, the regional market has a great opportunity in getting the market horizon expanded by increasing the number of treatments done for dermatological problems with light therapy. In Europe, the growth of this segment would be substantial as several countries like France, Germany, the UK, and others would show growth in their reception of the light therapy. This would happen mostly due to increasing awareness and spending capacity.

The Asia Pacific region would benefit from the number of people seeking therapy with this to counter their psychological issues. Growth in a number of people having trouble with depression and anxiety can increase the chance for the light therapy market growth. In the Middle East & Africa, the market would suffer from a lack of awareness regarding both dermatological and psychological issues and poor investment capacity.

Radiology Services Market 2020: Key companies Profile, their market Share and Growth Insights to 2023

2020-02-13T13:28:58.214Z

Radiology or diagnostic imaging, simply put, is a medical specialty that uses medical imaging for diagnosing and treating diseases within the bodies of humans and animals alike. Various imaging techniques are used for diagnosing or treating diseases such as magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography, ultrasound, and X-ray radiography.

The Global Radiology Services Market Size is predicted to touch USD 8,102.51 million at a 10.5% CAGR between 2019-2024, reveals the latest Market Research Future (MRFR) report.

Radiology tests enable physicians to see inside the body and are broadly categorized into interventional radiology and diagnostic radiology. The former technology is used for treating kidney problems, liver problems, back pain, fibroids in the uterus, blockages in the veins and arteries, and treating tumors or cancers. Through diagnostic radiology, doctors diagnose the causes of a patient’s symptoms, screen for various illnesses including heart disease colon cancer, or breast cancer, and monitor how well a patient’s body responds to treatments that they are receiving for their condition or disease.

Various factors are propelling the radiology services market growth. These factors, as per the new Market Research Future (MRFR) report, include the growing prevalence of chronic diseases, advancements in technology, demand for procedures that are minimally invasive, rising expenditure in R&D, and excellent strategies adopted by key players such as product launches. Additional factors pushing market growth include accessibility of reimbursement for radiology and developments in teleradiology.

On the flip side, lack of medical infrastructure, scarcity of skilled professionals, high risk of diseases resulting from radiation, and high price of radiology devices are factors that may restrict the radiology services market growth over the forecast period.

Key Players

Foremost players profiled in the global radiology services market report include Virtual Radiology (vRAD), Teleradiology Solutions Inc, Telemedicine Clinic, Telediagnostics Services Pvt. Ltd., Siemens Healthcare, RamSoft Inc., Radisphere National Radiology Group Inc., Onrad, Inc, Medica Reporting Ltd., Global Diagnostics, Everlight Radiology, Cybernet Medical Corporation, and 4ways Healthcare Limited.

Industry News

October 2019: North India’s leading hospital chain Saket, Max Super Specialty Hospital, has partnered with Fujifilm India, a renowned name in the development as well as the application of information innovations and imaging. Owing to the shortage of limited experts and radiologists in breast cancer diagnostics, the two giants have joined hands for training physicians in early cancer detection.

Browse More Information @ https://www.marketresearchfuture.com/reports/radiology-services-market-7904

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the radiology services market on the basis of end user, technology, application, and product type.

Based on product type, the radiology services market is segmented into portable digital radiology systems and stationary digital radiology systems. The stationary digital radiology systems segment has been again segmented into floor-to-ceiling mounted system and stationary ceiling-mounted systems. Of these, the stationary digital radiology systems segment will dominate the market over the forecast period chiefly owing to the growing demand for such systems in hospitals, its wide application, as well as, less radiation exposure.

Based on application, the radiology services market is segmented into orthopedic imaging, mammography imaging, dental imaging, chest imaging, and cardiovascular imaging.

Base on technology, the radiology services market is segmented into direct digital radiology and computed radiology.

Based on end user, the radiology services market is segmented into diagnostic centers, hospitals, and others.

Regional Analysis

By region, the radiology services market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Factors aiding growth in this region include increasing funding and investments, increasing chronic disease, increasing aging population, and initiatives undertaken by the government towards advanced healthcare infrastructure.

The radiology services market in Europe is predicted to have the second-largest share over the forecast period. Factors aiding growth in this region include favorable reimbursement policies, increasing R&D, and support and funding from the government for the healthcare sector.

The radiology services market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in this region include expansions by key market players, increasing investments in healthcare, and the growing prevalence of cancer.

The radiology services market in the MEA is predicted to have a small share over the forecast period.

Hemodynamic Monitoring Systems Market 2020 Global Growth Insights, Trends, Size, Share and Forecast to 2023

2020-02-13T13:01:56.592Z

Hemodynamic monitoring systems measure blood pressure directly from inside the arteries, heart, and veins. They also help to measure blood flow along with the oxygen content in the blood. Moreover, these systems possess interfaces that help to document electrophysiology (EP), peripheral, coronary, and diagnostic catheterizations.

The Global Hemodynamic Monitoring Systems Market Size is anticipated to touch USD 1,054 million at a 7.3% CAGR between 2017-2023, states the latest Market Research Future (MRFR) report.

Various factors are propelling the hemodynamic monitoring systems market growth. Such factors, according to the latest Market Research Future report, include awareness initiatives about hemodynamic monitoring systems by industry players, favorable compensation policies, rising aging population, rising number of hospital surgeries, the introduction of favorable government schemes for creating awareness about the respiratory and cardiovascular illness, and increasing rate of cardiovascular disorders. Additional factors propelling the growth of the hemodynamic monitoring systems market include increasing incidence of heart-related diseases, especially obesity, hypertension, and diabetes that causes heart-related disorders, including heart attacks, heart failures, and cardiac arrests, and technological advancements in both minimally noninvasive and invasive methods utilized for hemodynamic monitoring.

On the contrary, scarcity of skilled healthcare experts, adverse reactions, unfavorable reimbursement policies, and strict government regulations are factors that may hinder the hemodynamic monitoring systems market growth during the forecast period.

Key Players

Notable players profiled in the global hemodynamic monitoring systems market report include Uscom, NI Medical, CNSystems, CareTaker Medical, Osypka Medical GmbH, ICU Medical, Deltex Medical Group Plc., Cheetah Medical, LiDCO Group plc, PULSION Medical Systems SE, Edwards Lifesciences Corporation; Osypka Medical, Teleflex Incorporated, and Argon Medica. Key players have incorporated specific strategies to maintain their position in the market, such as regional expansion, product launch, mergers and acquisition, innovation, and others.

Industry News

September 2019- Baxter International has recently signed an agreement to acquire a leading manufacturer of non-invasive hemodynamic monitoring technologies, Cheetah Medical, to improve clinical outcomes through an established patient monitoring technology both to inform as well as guide the treatment decisions of clinicians.

Browse More Information @ https://www.marketresearchfuture.com/reports/hemodynamic-monitoring-systems-market-6678

Market Segmentation

The Market Research Future report offers a complete segmental analysis of the hemodynamic monitoring systems market based on end use, product, and type.

By product, the hemodynamic monitoring systems market is segmented into minimally invasive, monitors, and disposables. Of these, the monitors segment will have the largest share in the market during the forecast period.

By type, the hemodynamic monitoring systems market is segmented into non-invasive, invasive, and others. Of these, the invasive segment will dominate the market during the forecast period.

By end user, the hemodynamic monitoring systems market is segmented into home care settings, ambulatory care centers, clinics, hospitals, and others. Among these, hospitals and clinics will lead the hemodynamic monitoring systems market during the forecast period.

Regional Analysis

By region, the hemodynamic monitoring systems market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific, and the Middle East and Africa. Of these, North America will dominate the hemodynamic monitoring systems market during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include rapid acceptance of advanced technologies, growing healthcare sector, high per capita healthcare expenditure, rising incidence of minor/major heart issues, rising prevalence of obesity, hypertension, and low/high BP that results to heart disorders and diseases.

The hemodynamic monitoring systems market in Europe will have the second-largest share during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include rising cardiovascular issues, favorable government initiatives, accessibility of advanced treatment facilities, and rising healthcare expenditure.

The hemodynamic monitoring systems market in the APAC region will have promising growth during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include favorable reimbursement and insurance policies, initiatives undertaken by the government to augment the quality of healthcare, rapid adoption of advanced healthcare technology, increasing incidence of cardiac disorders, and increasing geriatric population.

The hemodynamic monitoring systems market in the MEA will have moderate growth during the forecast period. Saudi Arabia and South Africa are the major contributors in this region.

Fertility Services Market 2020: Key companies Profile, their market Share and Growth Insights to 2023

2020-02-13T12:06:05.324Z

Fertility services comprise of various procedures used for treating fertility and genetic issues and help with conception. Services such as frozen embryo replacement (FER), in-vitro fertilization (IVF), artificial insemination, and infertility drugs help infertile couples, the LGBT community, and single parents to procreate and begin a family. These services help in conceiving as well as offer a safe and better alternative to surrogacy.

The Global Fertility Services Market Size is predicted to grow at an 8.50% CAGR between 2018-2023, states the latest Market Research Future (MRFR) report.

Various factors are propelling the fertility services market growth. Some of these factors, according to the Market Research Future report, include increasing incidence of different medical ailments such as sexually transmitted diseases (STDs), polycystic ovarian syndrome (PCOS), and endometrium tuberculosis which may cause infertility, lack of financial stability, expanding career-oriented population base, and increase in marketing and advertising of medical facilities for promoting artificial reproduction. Additional factors pushing market growth include health insurance portability, an increase in disposable income, easy availability of advanced medical technologies in IVF devices, an increase in infertility rates, and an increase in the prevalence of delayed pregnancies.

On the flip side, low awareness levels, reimbursement issues associated with fresh IVF cycles, and high costs of fertility services are factors that are likely to deter the fertility services market growth over the forecast period.

Key Players

Notable players profiled in the fertility services market report include Vitrolife (US), Ferring Pharmaceuticals Inc. (US), CARE Fertility Group Limited (UK), CooperSurgical Inc (US), Irvine Scientific (US), Cook Medical (US), and Merck KGaA (Germany). Key players have incorporated several strategies to suffice the needs of the customers and stay ahead in the competition. These strategies include partnerships, collaborations, joint ventures, recent developments, mergers and acquisitions, and innovations.

Industry News

November 2019: American Hospital Dubai has recently entered into a partnership with the largest provider of IVC, Livio AB, with an aim to facilitate the creation of an IVF center that offers the finest possible pregnancy outcomes in the Middle East.

Browse More Information @ https://www.marketresearchfuture.com/reports/fertility-services-market-6281

Market Segmentation

The MRFR report offers a wide segmental analysis of the fertility services market on the basis of underlying cause and treatment.

Based on the underlying cause, the fertility services market is segmented into female and male infertility. Of these, the female infertility segment will dominate the market over the forecast period on account of endometrial tuberculosis, elapsed age of motherhood, the prevalence of obesity, and other forms of medical conditions.

Based on treatment, the fertility services market has been segmented into infertility drugs and assistive reproductive technology (ART). The assistive reproductive technology segment has been again segmented into frozen embryo replacement (FER), in-vitro fertilization (IVF), artificial insemination, and others. Of these, the ART segment will lead the market over the forecast period on account of its high success ratio, high adoption of this treatment, expendable incomes of patients, and easy availability of reimbursement policies covering such options.

Regional Analysis

By region, the fertility services market report covers the latest trends and growth opportunities across the Asia Pacific (APAC), Europe, the Americas, and the Middle East and Africa (MEA), Of these, Europe will spearhead the market during the forecast period for the significant increase in IVF, delayed marriages, low fertility rate, reimbursement policies, and state funds.

The Americas will have the second-largest share in the market over the forecast period on account of the presence of a developed healthcare system, advanced technologies, and growing incidence of hormonal imbalance in women due to obesity.

The Asia Pacific region is projected to grow at the fastest pace over the forecast period on account of the adoption of sophisticated technologies, favorable reimbursement policies, gynecological conditions, and changing lifestyle conditions.

The fertility services market in the Middle East and Africa is predicted to have a slow growth over the forecast period chiefly for the scarcity of advanced medical facilities, fewer investments in the healthcare industry, cultural and religious factors, scarcity in skilled medical professionals, and lack of awareness.

In Vitro Diagnostics Market By Key Vendors, Regions, Trends with Industry Study & Forecast to 2023

2020-02-13T11:29:14.083Z

The global in vitro diagnostics market is profiled in detail in the latest research report from Market Research Future (MRFR), providing a complete analysis of the global in vitro diagnostics market with view to its historical growth trajectory, present conditions, and likely future growth. The market’s movement has been captured and analyzed in the report with absolute accuracy, along with a detailed analysis of the market’s major drivers and restraints. The leading players in the global in vitro diagnostics market are also profiled in the report, giving readers a complete overview of the market’s competitive landscape.

The Global In Vitro Diagnostics Market Size is expected to progress steadily over the forecast period from 2018 to 2023, due to the growing demand for precision medicine and the growing advances in molecular diagnostics

In vitro diagnostics refer to diagnostics performed on living samples such as blood or other tissue taken from inside the body. In vitro diagnostics provides a higher level of accuracy in diagnosing diseases of various kinds. This has driven the demand for in vitro diagnostics in the healthcare sector. The growing prevalence of pathogenic diseases has been a major driver for in vitro diagnostics, as markers for pathogenic diseases are often seen in the patient’s blood. The growing efforts from government bodies aimed at wiping out diseases such as malaria and cholera have been a vital boost for the in vitro diagnostics market, as significant funds have opened up for research and advancement in the in vitro diagnostics sector. Growth of the healthcare sector in emerging regions of the world is likely to be a major driver for the in vitro diagnostics market over the forecast period.

The increasing demand for precision medication is also likely to drive the demand from the in vitro diagnostics market. The formulation of precision medication requires information about the patient’s blood and tissue structure, including genetic analysis. This has emerged as one of the most promising areas within the in vitro diagnostics market in recent years, as genetic research and genomics have emerged strongly within the healthcare sector in the last few years. Growth in the demand for genetic analysis in the healthcare sector is likely to remain one of the crucial drivers for the global in vitro diagnostics market over the forecast period.

Competitive Analysis:

Leading players in the global in vitro diagnostics market include Danaher Corporation, Bio-Rad Laboratories Inc., Siemens AG, F. Hoffman-La Roche AG, Ortho Clinical Diagnostics, Grifols S.A., Qiagen NV, BioMerieux S.A., Sysmex Corporation, Becton Dickinson and Company, DiaSorin S.p.A., Abbott Laboratories, and Thermo Fisher Scientific.

In January 2020, Co-Diagnostics Inc. and CoSara Diagnostics Pvt. Ltd. launched new in vitro diagnostic tests in India, for the detection of HPV, tuberculosis, malaria, and hepatitis B and C.

In December 2019, Nanopec released a new class of nano-structured ceramic films intended for use in in vitro diagnostic kits.

Segmentation:

The global in vitro diagnostics market is segmented on the basis of product, technology, application, end use, and region.

By product, the global in vitro diagnostics market is segmented into reagents and kits, instruments, and data management software.

By technology, the global in vitro diagnostics market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, and hematology.

By application, the market is bifurcated into infectious diseases and noninfectious diseases.

By end use, the global in vitro diagnostics market is segmented into hospitals, laboratories, and academic institutes.

Browse More Information @ https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165

Regional Analysis:

The Americas holds a dominant share of 39.4% in the global in vitro diagnostics market and is likely to remain the leading revenue generator over the forecast period. Widespread technological advancement in the healthcare sector and growing healthcare expenditure are the major drivers for the in vitro diagnostics market in North America. Europe is the second largest regional market, followed by Asia Pacific. APAC is likely to make steady progress in the market over the forecast period, as leading economies in the region have taken several steps to enhance their healthcare sector and make it competent to global standards.

Foley catheters Market 2020: Key companies Profile, their market Share and Growth Insights to 2023

2020-02-13T11:04:50.320Z

A foley catheter is commonly known as a flexible urinary drainage tube that passes through the urethra and subsequently into the bladder with the aid of a tiny water-inflated balloon. They technology for the same is improving at a continuous pace and is bringing forward new opportunities in the market. These products are usually recommended by healthcare experts and providers for individuals who suffer from bladder-related issues like urinary incontinence and urinary retention. The rising incidence of urologic diseases across the globe is the primary driver pushing the market growth of foley catheters.

The Global Foley Catheters Market Size was analyzed by Market Research Future (MRFR) and it was projected that a decent CAGR of 7.8% will be attained by the market over the forecast period of 2014 to 2023. The valuation of the foley catheters market was further stated to surpass its previous valuation to reach USD 987.3 million by 2023.

Competitive Landscape

The global foley catheters market comprises a host of key players. This includes names like Medline Industries Inc. (US), Cook (US), Teleflex (US), B. Braun Melsungen AG (Germany), Coloplast Ltd (Denmark), and Medtronic (Republic of Ireland).

Market Segmentation

The global foley catheters market has been segmented in terms of type, end-user, and material.

By material, the market includes silicone elastomer coated latex, silicone, silicone elastomer coated latex, latex, polytetrafluoroethylene PTFE (Teflon) coated latex, hydrophilic polymer coated latex, and others. The latex segment holds the largest share in the global market of foley catheters. Whereas, the hydrophilic polymer coated latex segment is anticipated to grow during the forecast period at a notable pace of 8.3%.

By type, the market is segmented into 4-way catheters, 3-way catheters, 2-way catheters, and others. The 2-way catheters segment leads the global market with the largest percentage of share to its name. The segment is anticipated to grow at a considerable pace to attain a revenue worth USD 527.4 by 2023.

By end-users, the market divides into medical research center, hospitals, and ambulatory surgery centers.

Browse More Information @ https://www.marketresearchfuture.com/reports/foley-catheter-market-922

Regional Analysis

The global foley catheters market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Rest of the World (RoW).

The North American region is estimated to be the leading contributor for Foley catheters in the coming years. The growth of the regional market can be credited to the large pool of money being invested in research and development activities and increasing product development being made herein. Back in 2016, the market in North America stood at a valuation of USD 228.8 Million and is expected to surpass the same by the end of the ongoing assessment period. The region also includes established healthcare facilities alongside attractive reimbursement policies, which are collectively influencing the growth of the market.

The European region is reported to maintain its second position in the global foley catheters market. This is due to the rising adoption of some of the latest and advanced products as well as technologies in this region. The market is reported to reach a valuation of USD 306.1 million by the end of the forecast period. In Europe, the U.K. is slated to experience the fastest growth percentage, while Germany is expected to dominate the regional market.

The Asia Pacific region holds an important position in the market of foley catheters globally. The regional market is said to experience rapid growth rate in the coming years. The growth of the Asia Pacific market can be attributed to the widespread incidence of various urological diseases and the increasing expenditure in the healthcare sector. Emerging nations like China and India are primed to be higly lucrative areas for the market due to the prevalence of chronic diseases, expanding geriatric population, and accelerating demand for advanced therapies as well as products.

Digital Pathology Market 2020 Global Trend, Segmentation and Opportunities, Forecast 2023

2020-02-13T10:42:30.062Z

Digital Solutions in-sync with healthcare empower manifold avenues in terms of cost efficiency and market growth that is increased productivity, better patient outcome, reduced expenses for unsuitable treatment, and a reduction in administrative capital expenditures.

In the healthcare sector, hospitals are getting more inclined towards automating and streamlining the procedures that normally take place amid the delivery of diagnosis and digitization of the tissue sample, which helps in improving reliability and speed. Sample queuing and scanning, annotation, case generation, sharing, and storage, support in structuring the task and maintaining the workflow, reduction in the time spent by technicians and pathologists are some of beneficial factor responsible for the rising adoption rate and driving the global digital pathology market.

The Digital Pathology Market Size is predicted to reach around $8305.6 Million and grow at CAGR of 13.4% depending on the climb in adoption rates during the forecast period, 2017-2023, according to Market Research Future.

Growing penetration of digital solutions in radiology and organization stressing more on Electronic Health Records across the healthcare segment is predicted to drive the progress of the global market.

Increasing number of industry players shifting their development strategies towards building digital pathology services and growing penetration of digital pathology systems in developed as well budding regions is expected to stimulate the demand for the global pathology market.

Major Players

Key players are adopting various strategies such as expansion, acquisition, and technology-driven product development to stay competitive in the global market. Some of the noteworthy key players in the digital pathology market comprise Huron Digital Pathology Inc, F. Hoffmann-La Roche Ltd., Definiens, Mikroscan Technologies, Inc., 3DHISTECH Ltd., Inspirata, Danaher Corporation (Leica Biosystems GmbH), Olympus Corporation, and Koninklijke Philips N.V. among others.

Industry Updates

In August 2019, Philips made public that Taipei Veterans General Hospital (TPVGH) will make use of Philips IntelliSite Pathology Solution to create first fully digital pathology department in Taiwan. By enabling tissue samples to be remotely monitored within virtual pathology network in hospitals, the Philips IntelliSite Pathology Solution will assist in TPVGH to enhance quality of diagnoses and upgrade patient safety. Philips IntelliSite Pathology Solution is intended for in-vitro diagnostic purposes to analyze and understand digital images of surgical pathology slides.

Market Segmentation

The global digital pathology market is broadly bifurcated into type, application, product, and end-users.

The type segment is segmented into animal pathology and human pathology.

The global digital pathology market is also divided into hardware and software, based on product.

Based on application, the global market is segmented into mhealth, disease diagnosis, and drug discovery.

Further, the global digital pathology market is also classified on the basis of end-users; this includes diagnostic centers, hospitals, and other healthcare facilities.

Browse More Information @ https://www.marketresearchfuture.com/reports/digital-pathology-market-1955

Regional Insights

The global digital pathology market is led by North America due to its noteworthy market share. Sophisticated healthcare infrastructure and expenditures in Canada and the US drives the growth in the regional market. The market is anticipated to flourish throughout the forecast period. Existence of leading market players in the region fuels the growth of the North American digital pathology market.

Europe stands at the second position in the global market following North America. European digital pathology market is majorly driven by government aid for research and development, high-tech healthcare facilities, dedicated research funds, and patient population. Regions such as Germany and the UK are major drivers of the digital pathology market in Europe.

Moreover, the evolving healthcare industry with the digitization holding major role, the Asia Pacific market is developing rapidly. It is also anticipated to spur at great pace in the coming period. Favorable government policies and growing awareness about technology advancement in emerging nations such as China and India are the key drivers of the global market.

Clinical Nutrition Market 2020 Industry Analysis, Share, Growth, Trends and Forecast 2027

2020-02-13T10:09:55.545Z

Over the previous decade, the real number of patients suffering from metabolic issues and occurrence diseases has expanded from a decade coupled with rising need for a novel treatment is posing like opportunities for growth to tap in the developing countries.

It has augmented the healthcare expenditure and is estimated to be there as a trend over the coming decade to benefit the market growth during this period. Along these factors, the healthcare expenditure is especially across several countries around the world are impacting on the growth owing to its wide demand and unmet needs for advanced treatments and drugs. Additionally, the many financing opportunities for the key players to offer the newer clinical nutrition programs and increasing investment from government are benefiting growth of the global clinical nutrition market. Also, the organizations such as National institutes of Health, Robert Woods Johnson Foundation, US Department of Agriculture, and Nestle Foundation are estimated to fuel the market growth in coming future.

The Clinical Nutrition Market is estimated to expand at a CAGR of 6.0% during the forecast period from 2019 to 2027. This growth can be attributable on the factors impelling growth including increasing prevalence of metabolic issue, expanding working class, and high spending on services and wellbeing globally and especially in the developing economies.

Clinical malnutrition is a condition, which can be treated with involvement of advanced treatments and nutritional food. The clinical nutrients and nutritional food with consideration as a proper medication, and supplements. Additionally, clinical nutrition products help keeping patients healthy and aiding to improve the metabolic system in human by supplying passable supplements, including vitamins, minerals, and other necessary supplements. Increasing consumption of these clinical nutrition are likely to drive the market during the estimated time frame.

Competitive Analysis:

Some of the major companies in the global clinical nutrition market include Abbott Laboratories, Baxter International, Inc, B. Braun Melsungen AG, GroupeDanone, Nestlé S.A, Mead Johnson Nutrition Company, Hospira, Inc, Fresenius Kabi AG, and Perrigo Company Plc. These players are trying to initiate programs for awareness of improving knowledge and benefits of consuming clinical nutrition. Such factors are likely to benefit their sales in coming years.

Industry News:

In 2019, ASPEN and Fresenius Kabi are working together for awareness among clinicians by providing nutritional support by promoting a series of videos highlighting best applications for administering, dosing, preparing, and intravenous lipid emulsions (ILE). Such information and awareness are fueling the market growth in coming future.

In 2019, BSM Partners announced that the company is merging with the R.M. Streeter Animal Nutrition to form a BSM Clinical Nutrition. Through this merger, the firm will enhance its nutritional standards and collaborate with BSM Partners' clients to create healthier.

Segmentation:

The clinical nutrition market is segmented on product and region.

On the based on the product, the market is segmented into infant nutrition, enteral nutrition, and parenteral nutrition. On the basis of infant nutrition, the market is further segmented into milk based, organic, soy based, probiotic/prebiotic, and other. On the basis of enteral nutrition, the market is segmented into standard and for chronic illness.

Browse More Information @ https://www.marketresearchfuture.com/reports/global-clinical-nutrition-market-829

Regional Analysis:

Regionally, the clinical nutrition market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, Asia Pacific is anticipated to be the largest market owing to presence of countries such as China and India. Additionally, comparatively higher birth rates, are expected to spur the demand for clinical nutrition products in the region.

North America accounted for third-largest share of around 23.1% share of overall revenue in 2014 and is estimated to witness fastest growth in the coming years. This growth is attributable to the increasing consumer awareness about health and wellbeing in the region. Additionally, high cost of healthcare is augmenting adoption of clinical nutrition products, which are driving growth of the global clinical nutrition market.

Clinical Laboratory Services Market 2020 Industry Analysis, Share, Growth, Trends and Forecast 2023

2020-02-12T13:41:56.181Z

Clinical Laboratory Services Market Driven by Growing Prevalence of Cancer, Diabetes

Growing Demand for Surefire Drugs, Disease Treatments to Drive Clinical Laboratory Services Market

The Global Clinical Laboratory Services Market is expected to reach a valuation of more than USD 274 billion by 2023, according to the latest research report from Market Research Future (MRFR). The global clinical laboratory services market is expected to gain strongly from the increasing healthcare expenditure and the increasing demand to find definitive cures to a number of diseases. The report profiles the global clinical laboratory services market in detail, providing a thorough outlook on the market’s major drivers and restraints. The major economic factors enabling the growth of the clinical laboratory services market are profiled in detail in the report to provide a conclusive explanation of the market’s economic background. The competitive landscape of the global clinical laboratory services market is also explained in detail in the report with the help of company profiles of the leading players operating in the market.

Clinical laboratory services have taken on a vital role in the healthcare sector in recent years due to the increasing emphasis on clinical research. Various areas of clinical research, such as biochemical research, genetics research, and cytological research, have emerged as important in curing problematic diseases such as diabetes and cancer. This has driven the demand for clinical laboratory services in the last few years. Medical research into cellular interactions and genetics has made vital inroads into cancer treatment in the last few years, with further advances expected in the coming years. This has augured well for the clinical laboratory services market, which has received a growing demand in regions with a burgeoning healthcare sector, including North America, Europe, and leading economies in Asia Pacific.

The increasing demand for further research into medical conditions such as cancer, hematological diseases, and genetics is likely to remain the major driver for the clinical laboratory services market over the forecast period. The growing prevalence of cancer and the continued lack of success in curing cancer with traditional means is likely to lead to a growing demand for innovative, groundbreaking ways to treat the disease. This is likely to drive the clinical laboratory services market at a strong growth rate over the forecast period.

Competitive Analysis:

Leading players in the global clinical laboratory services market include Sonic Healthcare, Cerba Healthcare, Eurofins Scientific, ACM Medical Laboratory, Synlab International, Quest Diagnostics Inc., Lifelabs Medicals Laboratories, Amedes Holdings, Adicon Clinical Laboratory, Clinical Reference Laboratory, Bio-Reference Laboratories, Unilabs, Spectra Laboratories Inc., Mayo Medical Laboratories, and Laboratory Corporation of America Holdings.

Browse More Information @ https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145

In December 2019, Quest Diagnostics completed the purchase of some assets of Boston Clinical Laboratories. The assets will be transferred to Quest’s laboratory in Marlborough, MA.

Segmentation:

The global clinical laboratory services market is segmented on the basis of type, application, and region.

By type, the global clinical laboratory services market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, genetic testing, and others.

By application, the global clinical laboratory services market is segmented into independent, laboratory, reference laboratory, and hospital laboratory.

Regional Analysis:

North America is a major regional market for clinical laboratory services and is likely to retain top spot over the forecast period. The growing number of clinical laboratories in the U.S. is the major driver for the clinical laboratory services market in North America. The U.S. is likely to remain the leading regional player in the global clinical laboratory services market on the basis of country. The advanced state of the healthcare sector in North America, particularly the U.S., has led to a strong foundation for the clinical laboratory services market, due to which the market has been able to grow at a strong rate. The growing awareness about lifestyle diseases such as diabetes and cardiovascular diseases in North America is also likely to drive the demand for clinical laboratory services in the region.

Asia Pacific is likely to emerge as an important regional market in the global clinical laboratory services market over the forecast period. China, India, Japan, and South Korea are likely to play a key role.